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Objectives. The aim of this study was the scintigraphic evalua-
tion of clinical no-reflow phenomenon.
Background. In patients with acute myocardial infarction, the
relationship of the severity of reduction of microvascular reflow to
the ischemia time or to the secondary extension of myocardial
necrosis is poorly understood, and we accordingly conducted a
scintigraphic evaluation of clinical no-reflow phenomenon.
Methods. The group studied consisted of 25 consecutive pa-
tients with their first acute myocardial infarction. After recanali-
zation, each patient received intracoronary injections of
technetium-99m macroaggregated albumin (MAA).
Results. Eight patients (32%) had absent tracer uptake (scin-
tigraphic no-reflow phenomenon). Fourteen patients showed ab-
sent or moderately reduced MAA uptake (group 1) and 11 showed
slightly reduced or normal uptake (group 2). The time to recan-
alization was significantly longer in group 1 than in group 2
(290.4 6 130.6 min vs. 177.3 6 93.5 min; p 5 0.0238). In chronic
phase, the thallium-201 (Tl-201) defect score index was signifi-
cantly larger (p < 0.01) and regional ejection fraction was
significantly lower (p < 0.01) in group 1 compared with corre-
sponding values in group 2. No significant deterioration from
acute phase to chronic phase in either Tl-201 defect score index or
regional ejection fraction was found in either group (two-way
repeated measures analysis of variance).
Conclusions. These findings suggest that scintigraphic no-
reflow phenomenon occurs in a subgroup of patients without
angiographic no-reflow phenomenon, that the myocardial damage
depends on the severity of microvascular damage and that pro-
longed ischemia time may increase the likelihood of “microvas-
cular no-reflow phenomenon.”
(J Am Coll Cardiol 1998;32:898–903)
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Early reperfusion is well known to reduce infarct size and
improve survival. However, there are patients with successful
early recanalization who do not show reduction of the infarct
size in the chronic phase (1). One possible explanation for the
failure of infarct size reduction is disturbance of microcircula-
tion during epicardial coronary reperfusion (2–10). Kloner et
al. (3) found that, after 90-min occlusion and reperfusion in
experimental animals, the inner layer of the myocardium had
little or no blood flow, despite removal of the epicardial
coronary obstruction. This has been termed the “no-reflow
phenomenon.” There are several unanswered questions about
this phenomenon in humans, including the frequency, the
relationship of its degree to the ischemia time to recanalization
of an infarct-related artery and to myocardial damage, and
whether secondary extension of infarcted segments occurs due
to the disturbance of microcirculation during reperfusion.
The methods of assessment of microvascular circulation
immediately after recanalization in clinical settings are limited
(11–17). In this study we evaluated the reduction of microvas-
cular reflow using intracoronary injection of technetium-99m
macroaggregated albumin (MAA) after coronary recanaliza-
tion. The objective of this study was the scintigraphic evalua-
tion of the frequency of clinical no-reflow phenomenon, the
relationship of the severity of disturbance of intramyocardial
microcirculation to the ischemia time for successful recanali-
zation and to the myocardial damage in the chronic phase and
the presence or absence of secondary infarct extension.
Methods
Patients. The study population consisted of 25 consecutive
patients with their first acute myocardial infarction. The acute
myocardial infarction was verified on the basis of clinical,
electrocardiographic (ECG) and enzymatic criteria. Inclusion
criteria were one-vessel disease and grade 3 reflow according
to the Thrombolysis In Myocardial Infarction (TIMI) (18)
criteria. Informed consent was obtained from each patient.
Acute coronary arteriography and coronary angioplasty.
Selective coronary arteriography (CAG) of both the left and
right coronary systems was performed in several projections
before percutaneous transluminal coronary angioplasty
(PTCA). All patients were monitored continuously by three-
lead ECG. Coronary arteriography of the infarct-related artery
and standard 12-lead ECG were recorded at each occurrence
of ST-segment changes, arrhythmias, chest pain or hypoten-
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sion. The collateral flow was graded by methods previously
described (0 5 no filling of collateral vessels; 1 5 filling only of
branches but no distal filling of the infarct-related artery; 2 5
visualization of part of the vessel distal to the lesion; and 3 5
ready visualization of most or all of the vessel distal to the
lesion) (19). Collateral vessels graded 2 or 3 were considered
to show good collateral circulation.
If the infarct-related artery showed TIMI grade 0 to 2 or
grade 3 with stenosis ^90%, PTCA was attempted. The time
to recanalization was defined as the interval from the onset of
chest pain to the appearance of TIMI grade 3 reflow after
PTCA, or to the first visualization on CAG in patients with
spontaneous recanalization (TIMI grade 3). Four weeks after
reperfusion, the patency of the infarct-related artery was
confirmed in 23 of the 24 patients examined. One patient
refused to undergo a repeat CAG. Ischemic event was not
observed during the follow-up period in any patient.
Serial evaluation of left ventricular function was conducted
using cineventriculograms obtained in 30° right anterior
oblique projection before PTCA and 4 weeks after the onset of
acute myocardial infarction. The regional ejection fraction of
the infarcted area was determined by the area method de-
scribed by Gerberg et al. (20).
Scintigraphic examinations. Intracoronary MAA scintigra-
phy. After the angiographic diagnosis of reperfusion, each
patient received intracoronary injections of MAA. To avoid
the effects of hyperemic high flow due to the contrast medium,
intracoronary MAA infusion was performed at least 20 min
after the last injection of contrast medium (21). Each patient
received a single hand-pressure injection of approximately
300,000 MAA particles (mean size per particle, 22.6 mm)
labeled with 27 MBq (1.0 mCi) of technetium-99m pertechne-
tate into both coronary arteries (left coronary artery, 0.7 mCi;
right coronary artery, 0.3 mCi) (21–24). The particles were
added to the injections of contrast material (24). This proce-
dure allows documentation of the actual flow of contrast
material and particles in the proximal vessel with identification
of subselective injections into the circumflex or left anterior
descending coronary artery (24). The subselective injection
was not documented in this study. Before and after the tracer
injection, any new symptoms, ECG changes and arterial pres-
sure were monitored. Following completion of the catheteriza-
tion procedure, patients were taken directly to the Nuclear
Medicine Laboratory; imaging was usually started within 1 h of
the tracer injection. Single-photon emission computed tomog-
raphy (SPECT) imaging was performed using a Toshiba GCA-
602A digital gamma camera equipped with a high-resolution
low-energy collimator (energy peak, 140 KeV; energy window,
620%). Thirty images were acquired over a 180° arc from the
50° right anterior oblique position to the 40° left posterior
oblique position, with each image being acquired over 30 s. All
projection images were acquired into 64 3 64 image matrices.
Prereconstruction filtering of the projection data sets was
performed using a Butterworth filter (Tokyo, Japan). Filtered
backprojection in conjunction with a ramp filter was used to
reconstruct the transaxial tomograms, which were then reori-
ented into short-axis images perpendicular to the long axis of
the left ventricle. The SPECT images were obtained with a 0%
lower cut-off level. Attenuation correction was not performed.
In the visual interpretation of the SPECT images, short-axis
and vertical long-axis tomograms were used. As a measure of
the myocardial perfusion defect depicted on the scintigrams,
the radioisotope uptake was scored using a 20-segment analysis
(6 basal, 6 middle and 6 apical segments identified on the
short-axis tomograms and 2 apical segments on the vertical
long-axis tomograms); a 4-point defect score was calculated for
each segment (0 5 normal; 1 5 slightly reduced; 2 5 moder-
ately reduced; 3 5 absent uptake) (Fig. 1). In addition, the
MAA SPECT images were analyzed quantitatively. The count
for the segment (noninfarcted segments) with the highest
count was set at 100%, and the counts in the infarcted
segments were normalized to that segment. The value (percent
count) represents the percent maximal uptake of the tracer in
the infarcted segments.
Abbreviations and Acronyms
CAG 5 coronary arteriography
CK 5 creatine kinase
ECG 5 electrocardiography
MAA 5 macroaggregated albumin
MCE 5 myocardial contrast echocardiography
PTCA 5 percutaneous transluminal angioplasty
SPECT5 single-photon emission computed tomography
TIMI 5 Thrombolysis In Myocardial Infarction
Tl-201 5 thallium-201
Figure 1. The grading of technetium-99m macroaggregated albumin
single-photon emission computed tomographic defect score in patients
with anterior myocardial infarction. A four-point defect score system
was employed (normal 5 0, Panel A; slightly reduced 5 1, Panel B;
moderately reduced 5 2, Panel C; and absent uptake 5 3, Panel D).
The short-axis slices from apical to basal are displayed on the left and
vertical long-axis slices on the right.
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Serial thallium-201 (Tl-201) scintigraphy. Each patient was
injected intravenously with 111 MBq (3.0 mCi) of Tl-201 at
rest, in both the acute phase (within 30 h of the MAA SPECT
imaging) and the chronic phase (24.5 6 6.5 days after the
MAA SPECT imaging). Ten minutes after injection, SPECT
acquisition was performed through a 20% window centered on
the 72-KeV X-ray peak of the tracer. As undertaken for MAA
imaging, the Tl-201 SPECT images were acquired over 180°.
The data acquired at the Tl-201 SPECT study were processed
identically to the MAA SPECT study using the same filters.
The images were obtained with a 30% lower cut-off level.
Studies of MAA and Tl-201 were aligned with each other and
the same reorientation was used.
Visual interpretation of the Tl-201 SPECT images was
performed by employing the 20-segment analysis with a 4-point
defect score as used in the MAA SPECT image interpretation.
The changes of the Tl-201 defect score index (total defect
score/number of infarct-related segments) from the acute to
the chronic phase were evaluated.
All MAA and Tl-201 SPECT images were visually inter-
preted by three experienced physicians without knowledge of
data for any of the patients. A perfusion defect score was
assigned when at least two of the observers agreed on the
score. If conflicting results between physicians occurred, dis-
agreements were resolved by consensus.
Cardiac enzyme measurements. Blood samples were col-
lected on admission, every 4 h for the first 24 h and every 6 h
for the next 24 h. Serum creatine kinase (CK) activity was
measured by the technique of Rosalki (25), and CK-MB
isozyme was measured with a radioimmunoassay. The peak
levels of both CK and CK-MB were estimated for each patient.
Statistical analysis (26). Values are expressed as the
mean 6 SD. Demographic variables were compared between
groups using Student’s t-test or chi-square testing, as appro-
priate. The correlation of the time to recanalization with
percent count of MAA uptake in infarct segments was assessed
with Spearman’s rank correlation, and linear regression anal-
ysis was done. For comparison of serial changes from acute
phase to chronic phase in Tl-201 defect score index and
regional ejection fraction, two-way (group—phase) repeated
measures analysis of variance (ANOVA) with Scheffe’s test
(Statistica Mac.version 4.0J) was used. Differences were con-
sidered significant at p , 0.05.
Results
MAA SPECT findings. In all 25 patients, images of suffi-
cient quality to be analyzed were obtained. Before and after
the tracer injection, new symptoms, ischemic ECG changes
and hypotension (^20 mm Hg) were not observed. Eight
(32%) of the 25 patients had absent tracer uptake scores
assessed visually. This group was considered to show scinti-
graphic no-reflow phenomenon. Table 1 lists the baseline
characteristics in the two groups divided by the grading of the
MAA defect score. Group 1 consisted of 14 patients who
showed MAA defect scores of 3 (8 patients) or 2 (6 patients),
and group 2 consisted of 11 patients who showed defect scores
of 1 (7 patients) or 0 (4 patients). There were no statistical
differences between the two groups in terms of age, gender or
the distribution of the infarct-related vessels. The differences
were not significant for the frequencies of either the sponta-
neous recanalization (TIMI grade 3 reflow) or the good
collateral vessels at first visualization at CAG. However, the
time to recanalization was significantly longer in group 1 than
in group 2 (290.4 6 130.6 min vs. 177.3 6 93.5 min; p 5
0.0238). The ischemia time to successful recanalization was
correlated with the percent count, as a measure of MAA
uptake, in the infarct-related segments (Fig. 2).
Variables of myocardial damage. The peak CK and
CK-MB isoenzyme activities were significantly higher in group
1 compared with group 2 (Table 2). The frequency of ST-
segment re-elevation immediately after recanalization (19) by
PTCA was higher in group 1 than in group 2 (7 of 14 vs. 1 of
7; p 5 0.0421). Since four patients in group 2 showed TIMI
grade 3 at first visualization by CAG, they were excluded from
the evaluation of ST-segment re-elevation immediately after
recanalization by the intervention.
Thallium-201 SPECT was performed in the acute phase
(between 24 and 30 h after the intracoronary MAA injections)
Table 1. Clinical and Angiographic Characteristics
Group 1
(n 5 14)
Group 2
(n 5 11) p
Mean age (yr) 65.1 6 8.9 62.4 6 16.2 NS
Sex (% male) 93 82 NS
Infarct-related vessel (% LAD) 79 45 NS
First visualization on CAG
TIMI 3 or with good
collaterals (n [%])
5 (36) 7 (64) NS
Mean time (min)
Symptoms to CAG 261.1 6 131.4 160.0 6 73.4 0.0229
Symptoms to recanalization 290.4 6 130.6 177.3 6 93.5 0.0092
Data are mean 6 SD or percentage. CAG 5 coronary arteriography; LAD 5
left anterior descending artery; NS 5 not significant; TIMI 5 Thrombolysis In
Myocardial Infarction trial.
Figure 2. Correlation of the time to recanalization from the onset of
symptoms of acute myocardial infarction with the percent count as a
measure of technetium-99m macroaggregated albumin uptake in the
infarct-related segments.
900 KONDO ET AL. JACC Vol. 32, No. 4
SCINTIGRAPHIC MICROVASCULAR NO-REFLOW PHENOMENON October 1998:898–903
and in the chronic phase in both groups (Table 3). Two-way
repeated measures ANOVA revealed that the Tl-201 defect
score index was significantly larger in the acute phase than in
the chronic phase (phase effect, p , 0.001) in both groups and
in group 1 than in group 2 (group effect, p , 0.001) in both
phases, to a similar extent (phase—group interaction, p 5 NS).
In each patient, the MAA and Tl-201 defect segments
correlated with the coronary anatomies. The correlation of the
extent of perfusion defect segments in each SPECT image was
1) Tl-201 . MAA in 9 patients, 2) Tl-201 5 MAA in 10
patients and 3) Tl-201 , MAA in 6 patients.
Left cineventriculogram of adequate quality was obtained
before and 4 weeks after PTCA in 11 of the 14 patients in
group 1 and in 9 of the 11 patients in group 2. For the regional
ejection fraction of the infarcted area, two-way repeated
measures ANOVA showed two main effects of the phase (p 5
0.0076) and the group (p , 0.001), and a significant interaction
(p 5 0.0356). Scheffe’s test revealed that the regional ejection
fraction significantly increased in group 2 from the acute to the
chronic phases (p 5 0.0200), whereas the change in group 1
was not significant (Table 3). Although there was no significant
difference between the groups in the regional ejection fraction
in the acute phase, the regional ejection fraction in the chronic
phase in group 1 was significantly smaller than that in group 2
(p , 0.01) (Table 3). Although significant deterioration was
not found in either group, two patients in group 1 showed
diminution of regional ejection fraction of ^9% from the acute
to the chronic phase. These two patients did not show deteri-
oration of the Tl-201 defect score index.
Discussion
Scintigraphic no-reflow phenomenon. Macroaggregated
albumin microspheres technique is considered to be an indi-
cator of blood flow at the precapillary or capillary level (23,27).
This indicates that the scintigraphic distribution of intracoro-
nary MAA imaging is related to the degree of disturbance of
intramyocardial microvascular flow after epicardial coronary
reperfusion. Schofer et al. (12) presented scintigraphic evi-
dence of no-reflow phenomenon acquired in human subjects
using intracoronary Tl-201 and MAA scintigraphy. They re-
ported that the residual MAA perfusion defect reflects the
area of no-reflow in the presence of normal filling and runoff of
the contrast medium in the epicardial infarct-related vessel.
However, they did not report the frequency of scintigraphic
no-reflow phenomenon or the relationship of the severity of
disturbance of MAA uptake to either the ischemia time or
myocardial damage. In addition, in their evaluation they
employed planar imaging. Recently, Morishima et al. (13)
examined the frequency of angiographic no-reflow phenome-
non. Severe disturbance of filling and runoff of the contrast
medium was seen in 14% of patients with successful recanali-
zation. In the present study, scintigraphic no-reflow phenom-
enon was recognized in 32% (8 of 25) of the patients without
angiographic no-reflow phenomenon. The disturbance of
MAA uptake showed variable degrees, and normally distrib-
uted MAA uptake was seen in only four patients (16%).
Relation between ischemia time and no-reflow phenome-
non. The time to CAG or successful recanalization from the
onset of symptoms of acute myocardial infarction was signifi-
cantly longer in patients with completely absent or moderately
reduced MAA uptake compared with those showing normal or
slightly reduced uptake. In addition, we found a negative
correlation between the ischemia time to successful recanali-
zation and the percent count for MAA uptake in the infarct-
related segments. Longer ischemia time to reflow promoted
the “microvascular no-reflow phenomenon.” This suggests that
the duration of ischemia is an important factor for determina-
tion of the degree of microvascular damage in human subjects
(28). In contrast, two clinical studies employing myocardial
contrast echocardiography (MCE) in patients with acute myo-
cardial infarction within 6 h of the onset revealed no significant
difference in time to recanalization between the groups with
and without no-reflow (16,29). This difference may be related
to the differences in the methods used for the evaluation of the
microvascular flow pattern. In these two studies qualitative
analysis was used to evaluate the grade of enhancement in risk
segments. The present study revealed the correlation between
ischemia time and the severity of reduction of intramyocardial
MAA uptake both qualitatively and quantitatively. We believe
that this is the first report of a correlation between ischemia
time and the severity of reduction of intramyocardial micro-
circulation in patients with acute myocardial infarction.
Relationship between disturbance of MAA uptake and
myocardial damage. Although the degree of disturbance of
MAA uptake in the left ventricular wall was variable, the
values of the myocardial damage parameters depended on the
severity of the disturbance of MAA uptake immediately after
successful recanalization. Furthermore, patients with com-
pletely absent or moderately reduced MAA uptake (group 1)
Table 3. Changes in Tl-201 DSI and r-EF
Group 1 Group 2
Acute Chronic Acute Chronic
Tl-20 DSI 1.98 6 0.66* 1.47 6 0.88*† 0.82 6 0.76 0.12 6 0.19‡
r-EF (%) 22.25 6 5.10 24.45 6 12.63* 27.01 6 8.43 42.92 6 9.40§
*p , 0.01 vs. group 2; †p 5 0.0453 vs. acute phase; ‡p 5 0.0105 vs. acute
phase; §p 5 0.0200 vs. acute phase. r-EF 5 regional ejection fraction; Tl-201
DSI 5 thallium-201 defect score index.
Table 2. Results for Variables of Myocardial Damage
Group 1 Group 2 p
Mean peak enzyme (IU/L)
Creatine kinase (CK) 4107.5 6 2224.3 1137.8 6 660.9 0.0008
CK-MB isozyme 454.1 6 292.4 109.4 6 58.1 0.0005
ST re-elevation (n*) 7/14 1/7 0.0421
*Numbers indicate the number of patients showing ST-segment re-elevation
immediately after successful recanalization among patients with TIMI grade 0 to
2 at first visualization by CAG. Abbreviations as in Table 1.
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had more marked myocardial damage despite patent infarct-
related arteries as they had higher peak CK and CK-MB
activity and larger Tl-201 defect score indexes compared with
patients showing normal or slightly reduced MAA uptake
(group 2). In addition, group 1 showed lower regional ejection
fraction of the infarct area compared with group 2 in the
chronic phase. These results seem to indicate that the myocar-
dial damage in the chronic phase is closely related to the
severity of scintigraphic disturbance of microcirculation imme-
diately after recanalization. Thrombolytic therapy or PTCA is
now an established treatment for acute myocardial infarction
(30). In some patients, however, these therapies fail to produce
limitation of infarct size or preservation of left ventricular
function, even if early epicardial coronary reperfusion is
successful (1). The present study reveals a discrepancy between
the angiographic and scintigraphic assessments for myocardial
blood flow and the results may explain, in part, the failure to
limit the infarct size in patients with successful recanalization.
Recently, Ito et al. (14–17) found that the presence of
no-reflow phenomenon revealed by MCE is a predictor of poor
recovery of left ventricular function. However, it is difficult to
grade the disturbance of microcirculation with the MCE
method. In contrast, the present study revealed that the
preservation of left ventricular function depended on the
severity of the MAA defect score immediately after successful
recanalization. In addition, the MAA defect score corre-
sponded to the percent maximal uptake of the tracer in our
patients. Thus, MAA techniques seems to offer an advantage
in the assessment of microcirculation compared with MCE.
Limitations. Ambrosio et al. (31) examined the concept of
the delayed no-reflow phenomenon experimentally. They de-
scribed that the phenomenon might occur during the course of
reperfusion and be an additional impairment to the “immedi-
ate no-reflow” at the time of reperfusion caused by microvas-
cular damage. They postulated the existence of progressive
impairment of blood flow of myocardium which was initially
well reperfused, and myocardial infarct extension. The present
study, however, did not reveal significant deterioration at the
chronic phase compared to the acute phase of either Tl-201
defect score index or regional ejection fraction in either group.
However, the Tl-201 SPECT at the acute phase was performed
between 24 and 30 h after the intracoronary MAA injections.
Therefore, the images acquired in the acute phase may not be
adequate for the evaluation of progressive myocardial infarct
extension by no-reflow phenomenon during reperfusion. We
employed serial cineventriculography as an additional source
of information to evaluate the changes of regional ejection
fraction. No patient showed deterioration as assessed by both
methods. Furthermore, histopathologic animal experiments
have shown that microvascular damage was not a primary
cause of the development of irreversible ischemic myocardial
cell damage (32). Therefore, no-reflow itself would not cause
additional tissue necrosis within the risk area. Thus, no-reflow
would be a marker of severely damaged myocardium and
microvasculature, but would not be a cause of additional
myocardial damage. The evaluation of the serial changes of
risk area from prerecanalization to the chronic phase in
patients with or without no-reflow phenomenon may confirm
the presence or absence of secondary infarct extension due to
continued postreperfusion ischemia in a clinical setting (6,10).
Conclusions. This prospective study demonstrated that
scintigraphic no-reflow phenomenon occurs in 32% (8 of 25) of
patients without angiographic no-reflow phenomenon, and
that the myocardial damage in the chronic phase depends on
the severity of the MAA defect score immediately after
recanalization. The ischemia time to reflow affects the severity
of microvascular damage as assessed using MAA scintigraphy.
In addition, there was no evidence of progressive infarct
extension due to disturbance of microvascular reflow in our
patients.
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